3 news items
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
VRNA
9 May 24
, performance or achievements to be materially different from our expectations expressed or implied by the forward-looking statements, including
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
HTGC
VRNA
9 May 24
cause our actual results, performance or achievements to be materially different from our expectations expressed or implied by the forward-looking
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024
VRNA
2 May 24
or achievements to be materially different from our expectations expressed or implied by the forward-looking statements, including, but not limited
- Prev
- 1
- Next